Advancing access, accelerating research, and improving outcomes in myeloma care.
The U.S. Myeloma Network (USMN) is a national clinical trials and education initiative designed to accelerate the development of innovative treatments for multiple myeloma while expanding equitable access to research opportunities.
Built in partnership with the International Myeloma Foundation’s trusted patient and scientific networks, USMN streamlines clinical trial activation and execution across academic and community settings to help bring promising therapies to patients faster.
At the same time, USMN develops culturally and linguistically capable clinical trial education and outreach programs that increase awareness, build trust, and improve participation among at-risk and historically underserved communities.
By combining scientific collaboration, operational efficiency, and patient-centered engagement, USMN is creating a faster, more inclusive pathway to the next generation of myeloma breakthroughs.